Recall D-1349-2022
Description: Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India. Manufactured for BluePoint Laboratories. NDC 68001-0313-56
Recall D-1349-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-1349-2022 |
| Event ID | 90677 |
| Distribution | Nationwide within the USA |
| Quantity | 4,160 vials |
| Recall Reason | Subpotent Drug |
| Drug Classification | Class III |
| Drug Code Info | 20220824 |
| Recall Initiation Date | 20220727 |
| Report Date | 20220824 |
| Classification Date | 20220817 |
| Address | 2550 John Glenn Ave Ste A Columbus, OH 43217-1188 United States |
| Recalling Firm | Amerisource Health Services LLC |
| Initial Notification | Letter |
| Similar To |